A public health expert explains emergency measures recently brought in to manage the impact of Omicron on our stressed health system.
Academic rigor, journalistic flair
Articles on Omicron variant
Displaying 81 - 100 of 151 articles
The health care system is hemorrhaging medical lab workers, in part because of COVID-19 infections and also because of burnout, low wages and better opportunities elsewhere.
A discussion on what the latest Resolve poll means for the Coalition, George Christensen and Anthony Albanese's chances in the election.
With decreasing teacher degree completion rates and low teacher retention, Australia was already facing a growing teacher shortage before the pandemic. But it’s about to get much worse.
As people living in long-term care homes brave another lockdown, communication is key and the presence of family members (virtually or through the window) is needed.
A legal scholar explains what the ruling means for other vaccine mandates and the government’s ability to protect public health.
Are economic drivers the reason for the reduced isolation period in the UK?
We’d all like some answers. But uncertainty over how we count COVID cases is complicating the picture. Here’s what to expect in the days and weeks ahead.
Ottawa’s travel ban against African countries made clear its underlying policy: What matters is not your test result, but where you’ve been. It’s yet another example of anti-Africa discrimation.
The new variant threatens to infect billions worldwide in early 2022.
The lack of preparation has been even more stunning than the miscalculation. As prime minister, Scott Morrison has to shoulder prime responsibility.
Research on how text messaging could provide mental health resources resulted in SaskWell, a texting service for people in Saskatchewan that provides 10 weeks of mental health and wellness prompts.
Having a range of immune cells that target different parts of the virus appears to make disease milder and could protect against future variants.
Some political and business leaders have, from the outset of COVID-19, downplayed the economic costs of mass illness. We’re now seeing the result.
Omicron is continuing the trend set by delta, causing symptoms that resemble the common cold.
Children are not the primary drivers of Omicron. And for the majority of children, COVID has been a mild disease. But there are many known harms from school closures.
Understanding the difference between COVID tests can help explain why the rules keep changing.
Omicron may be able to dodge antibodies, but it is no match for our killer T-cells.
People can counter the helplessness felt during the pandemic and build power by creating a sense of purpose and community amid the confusion of COVID-19.
Even with a variant like Omicron that may be more transmissible than earlier variants, vaccines remain the most effective tool for protection against COVID-19 and for ending the pandemic.
Top contributors
-
Professorial Fellow, University of Canberra
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Medicine, University of East Anglia
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Senior Lecturer, Medical Microbiology, University of Westminster
-
Principal Medical Scientist at National Institute for Communicable Diseases (NICD), National Institute for Communicable Diseases
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Canada Research Chair in Aging & Immunity, McMaster University
-
Professor, Biology, York University, Canada
-
Adjunct Professor: Department Internal Medicine, University of Pretoria
-
Director: SACEMA, South African Centre for Epidemiological Modelling & Analysis (SACEMA)
